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Background: Erythrocyte pyruvate kinase deficiency (PK deficiency) is an inherited hemolytic anemia that has been
documented in the Abyssinian and Somali breeds as well as random bred domestic shorthair cats. The disease
results from mutations in PKLR, the gene encoding the regulatory glycolytic enzyme pyruvate kinase (PK). Multiple
isozymes are produced by tissue-specific differential processing of PKLR mRNA. Perturbation of PK decreases
erythrocyte longevity resulting in anemia. Additional signs include: severe lethargy, weakness, weight loss, jaundice,
and abdominal enlargement. In domestic cats, PK deficiency has an autosomal recessive mode of inheritance with
high variability in onset and severity of clinical symptoms.
Results: Sequence analysis of PKLR revealed an intron 5 single nucleotide polymorphism (SNP) at position 304
concordant with the disease phenotype in Abyssinian and Somali cats. Located 53 nucleotides upstream of the
exon 6 splice site, cats with this SNP produce liver and blood processed mRNA with a 13 bp deletion at the 3’ end
of exon 5. The frame-shift mutation creates a stop codon at amino acid position 248 in exon 6. The frequency of
the intronic SNP in 14,179 American and European cats representing 38 breeds, 76 western random bred cats and
111 cats of unknown breed is 6.31% and 9.35% when restricted to the 15 groups carrying the concordant SNP.
Conclusions: PK testing is recommended for Bengals, Egyptian Maus, La Perms, Maine Coon cats, Norwegian Forest
cats, Savannahs, Siberians, and Singapuras, in addition to Abyssinians and Somalis as well an any new breeds using
the afore mentioned breeds in out crossing or development programs.
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During maturation of mammalian erythrocytes, the nu-
cleus and cellular organelles are lost [1,2]. Thus, the ma-
ture erythrocytes lack DNA and are unable to produce
RNA, rendering them incapable of division and repair
and limiting the functional lifespan of the circulating red
blood cell (RBC). Additionally, mitochondrial loss limits
ATP production within the RBC to glycolysis. The final
ATP yielding step of the Embden-Meyerof glycolytic
pathway is the conversion of phosphoenolpyruvate to
pyruvate via the regulatory enzyme pyruvate kinase.
Two structural genes encode pyruvate kinase (PK);
pyruvate kinase, liver and RBC (PKLR) and pyruvate kin-
ase, muscle (PKM2) [3]. Tissue- and development-specific
expression, as well as cellular metabolic needs, determine* Correspondence: ragrahn@ucdavis.edu
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reproduction in any medium, provided the orwhich of these genes is expressed [4-8]. Additionally, each
gene has isozymes generated by alternative splicing of
exons 9 and 10 in PKM2 and promoter selection,
with the corresponding exon 1, in PKLR L and R alleles
[9,10]. PKM2 generates the M1 and M2 isozymes. M1-PK
is produced in muscle and brain while M2-PK is
expressed in retina, lung, fat tissue, pancreas and rapidly
dividing cells such as embryonic and tumor cells [11].
In humans, the L and R isozymes are PKLR products
generated in the liver and reticulocytes, respectively.
Homologous sequence data protein prediction algorithms
suggest both forms are present in other primates but
experimental evidence for two forms is only supported in
humans, dogs (NM_001256262.1 and NM001256018.1),
mice (NM_013631.2, NM_001099779.1) and rats [12].
Perturbation of PK results in PK deficiency and ultim-
ately leads to hemolytic anemia. In humans, over 190 PK
mutations have been identified [13-21]. PK deficiency
has also been clinically characterized in several caninetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Dachshound [24], Cairn Terrier [25], Pug [26], and West
Highland White Terrier [27]. To date, affected large
breed dogs have been restricted to Labrador Retrievers
[26]. An exonic deletion (c.433delC) results in PK defi-
ciency in Basenjis [28], a 6 bp exon 10 insertion is causa-
tive in West Highland and Cairn Terriers [26,29],
missense mutations c.848T>C and c.994G>A result in
Pug and Beagle PK deficiency respectively and Labrador
Retrievers have a c.799C>T mutation that results in a
premature termination codon and loss of over 53% of
the protein [26]. It should be noted that not all Labradors
with clinical symptoms of PK deficiency have the
c.799C>T mutation [26]. Affected dogs present with clin-
ical signs as early as a few months to as late as several
years of age regardless of the causative mutation. Dis-
ease severity is variable but both Basenjis and Labradors
with the c.799C>T mutation have a more severe anemia
and shortened lifespan [26]. The initial sign of the dis-
ease commonly presents as exercise intolerance result-
ing from PK deficiency induced anemia.
Domestic cats also have an inherited PK deficiency.
The disease manifests as a chronic, intermittent,
hemolytic anemia. Typically, clinical symptoms include
but are not limited to: lethargy, diarrhea, pale mucous
membranes, lack of appetite, poor coat quality, weight
loss, icterus and occasionally splenomegaly. Blood
chemistry may reveal anemia, increased aggregated re-
ticulocyte counts, hyperglobulinaemia, hyperbilirubinae-
mia, and increased liver enzymes (for detailed,
longitudinal clinical symptoms see Kohn et al. 2000 and
2008) [30,31]. In a cohort of 25 affected cats, clinical
signs first manifested as early as six months and as late
as five years. Some cats died or required euthanization
while others maintained an adequate quality of life.
Thus, both severity of clinical presentation and age of
onset are variable.
The first documented report of feline PK deficiency
was in an Abyssinian cat [32]. Later, reports demon-
strated that Somalis, a longhaired variety of Abyssinians,
as well as random bred domestic shorthairs, had PK de-
ficiency. A proceedings abstract implicated a deletion of
the last 13 bases of exon 5 of R type PKLR from liver
cDNA in Abyssinian and Somali cats [33]. No correlat-
ing genomic deletion was detected but two intron 5
SNPs were mentioned, one of which was concordant
with disease. The nature, sequence, and location of the
SNPs were not disclosed. No sequence, gene, or SNP
data has ever been curated in any publicly available reposi-
tory regarding PK deficiency. However, subsequent re-
search evaluating geographic distribution and frequency of
the PK deficiency SNP in the Abyssinian and Somali
breeds, performed in collaboration with the reporting
laboratory, cites the proceedings abstract [30,34].In this study, PKLR mRNA was isolated from whole
blood and bone marrow from two cats heterozygous
for the historically proposed PK mutation and the gen-
erated cDNA was examined in its entirety for add-
itional mutations by sequence analysis. A concordant
SNP at position 304 of intron 5 was identified, as well
as two, non-correlated SNPs at intronic positions 303
and 320. The disease-associated SNP presence and fre-
quency was determined in 14,179 cats representing 40
breeds or populations. Fifteen groups (defined as a spe-
cific breed, samples that could not be assigned to a breed
and domestic random bred cats) possess the diagnostic
PK deficiency SNP at a frequency of 9.35%.
Methods
Samples for population frequencies
Buccal samples from cats (n = 14,179) were submitted
to the Veterinary Genetics Laboratory (VGL) (n =
12,630) at the University of California at Davis, CA or
Langford Veterinary Services (LVS) (n = 1,549) at the
University of Bristol, UK for genetic testing. Breed
identification was owner reported. DNA from VGL
submitted samples was isolated as previously described
[35]. LVS submitted samples were supplied from own-
ers as buccal swabs and DNA isolated as described
previously [36].
RNA and DNA isolation
Genomic DNA was isolated from peripheral RBC from
two cats heterozygous for the putative diagnostic SNP
and from a cat homozygous for the SNP but not pre-
senting with clinical signs of anemia. Total RNA was
isolated from bone marrow and liver samples from one
carrier cat and from RBC of the second carrier cat. Tis-
sues were stored in RNAlater (Qiagen Inc., Valencia CA,
USA) at −20°C prior to RNA isolation. All RNA was iso-
lated as previously described [37]. Samples were collected
from research animals housed at the Feline Genetics
Research Colony at UC Davis under Institutional Animal
Care and Use Committee protocol 15177.
Gene analysis
Feline genomic sequence data for PKLR generated by the
feline genome sequencing project (AANG00000000.2)
[38] was available for exons 2 and 6 through 11. Pri-
mers were designed using Primer3plus (http://www.
bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi)
flanking the exons to obtain splice boundaries (Table 1).
No genomic sequence was available in the public data-
base for cat PKLR exons 1, 3, 4, and 5. Complete
complementary cDNA was generated using Super-
script III first strand synthesis reaction (Invitrogen,
Carlsbad, CA) according to manufacturer’s gene specific
primer protocol.
Table 1 Genomic and cDNA primers and their locations for PKLR in domestic cats






























5' Race primer 5'-3' Sequence 5' Race primer 5'-3' Sequence
AUAP GGCCACGCGTCGACTAGTAC PKLR_5'_ex2/3R CCGGCCCAATGGTGGCG
* locations defined by feline assembly Dec. 2008 NHGRI/GTB V17e/felCat4.
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previously described [39]. All cDNA PCRs were per-
formed as two separate reactions in a total volume of 20 μl.
First round PCRs used 2 μl cDNA as the template while
second round reactions used 1 μl of the first round
amplicons in the following reaction: 2 mM MgCl2, 1X
Amplitaq Gold Buffer (Applied Biosystems), 1.25 mM
dNTPs, 0.5 μM of each primer and 0.75 units of Ampli-
taq Gold (Applied Biosystems). First round PCR reac-
tions were amplified under the following cycling
conditions in a 2720 Thermal cycler (Applied Biosys-
tems): 94°C for 4 min initial denaturation, followed by 5
cycles of 30 sec at 94°C, 2 min at 72o C, then 5 cycles
of 30 sec at 94°C, 2 min at 70°C and lastly 25 cycles of
30 sec at 94°C, 20 sec at 66°C and 2 min at 72°C. A 72°C
final incubation for 10 min was added to ensure full
product length for all amplicons. The second round ther-
mal cycle profile was as follows: 94°C for 4 min initial
denaturation, followed by 5 cycles of 30 sec at 94°C, 20
sec at 64°C and 2 min at 72°C, 5 cycles of 30 sec at
94°C, 20 sec at 62°C and 2 min at 72°C and 25 cycles
of 30 sec at 94°C, 20 sec at 60°C and 2 min at 72°C,
with a final extension at 72°C for 10 min. PCR products
were visualized by agarose gel electrophoresis and pre-
pared and sequenced as previously described [40]. Se-
quencing products for an individual cat were assembled
into a single gene contig using Sequencher analysis soft-
ware v4.1 (Gene Codes Corporation, Ann Arbor, MI).
Assembled contigs from each sample were aligned to
identify sequence variants.
The 5' untranslated region and exon 1 sequence data
were obtained using the GeneRacer Core Kit (Invitrogen)as previously described [37]. Amplified products were
sequenced and assembled as described above.Results
The complete PK type-R transcript sequence was
obtained from both a bone marrow and liver sample
of a carrier cat. The feline CDS R-type PK transcript
is 1,725 bp, contains 11 exons, and in silico translation
predicts a 574 amino acid protein. Sequence identity
to domestic dog, panda and human (GenBank Accession
Nos.: NM_001256262.1, XM_002928283, NM_000298,
respectively) is 89.9%, 89.7% and 87.6%, respectively, with
a protein homology of 89.7%, 88.7% and 88.0%, respect-
ively. A partial PK transcript was obtained from RBC, but
because it lacked the 5’ portion it could not be identi-
fied as an R-type or L-type transcript. Multiple attempts
failed to obtain the L-type mRNA transcript from liver,
bone marrow and RBCs.
Bone marrow and liver RNA from the carrier cat
yielded the wild-type-R transcript as well as a shor-
tened product (GenBank Accession #s JX951426 and
JX951427). The abbreviated transcript is identical to
wild-type at the sequence level with the exception of a
deletion of the last 13 bp of exon 5 (Figure 1). The same
abbreviated transcript was identified in the RBC of a sec-
ond carrier cat, however, the 5’ portion was not obtained.
In silico translation of this product results in a frame shift
and erroneous translation of the first 20 amino acids of
exon 6, followed by a premature stop codon at position
248 (Figure 1). This truncation results in a loss of the ter-
minal 57% of the mature PKLR type-R protein.
      520       530       540       550       560
-------+---------+---------+---------+---------+--
GAGACCGACGTGGAGCTAGTGAAGGGCTCCCGGGTGCTGGTGACCGTGGA Wt
 E  T  D  V  E  L  V  K  G  S  R  V  L  V  T  V  D
GAGACCGACGTGGAGCTAGTGAAGGGCTCCCGGGTGCTGGTGACCGTGGA Aff
 E  T  D  V  E  L  V  K  G  S  R  V  L  V  T  V  D 
      570       580       590       600       610
-------+---------+---------+---------+---------+--
CCCGGCGTTCCGGACGCGGGGGGACGCGAACACCGTGTGGGTAGACTACC Wt
  P  A  F  R  T  R  G  D  A  N  T  V  W  V  D  Y
CCCGGCGTTCCGGACGCGGGGGGACGCGAACACCGTGTGGGTAGACTACC Aff
  P  A  F  R  T  R  G  D  A  N  T  V  W  V  D  Y
      620       630       640       650       660
-------+---------+---------+---------+---------+--
CCAATATCGTCAAGGTCGTGTCGGTGGGGAGCCGCATCTACATAGACGAC Wt
P  N  I  V  K  V  V  S  V  G  S  R  I  Y  I  D  D 
CCAATATCGTCAAGGTCGTGTCGGTGGGGAGCCGCATCTACATAGACGAC Aff
P  N  I  V  K  V  V  S  V  G  S  R  I  Y  I  D  D 
      670       680       690       700       710
-------+---------+---------+---------+---------+--
GGGCTCATCTCCCTCCAGGTGCAGAAAATCGGCCCGGAGGGGCTGGAGAC Wt
 G  L  I  S  L  Q  V  Q  K  I  G  P  E  G  L  E  T
GGGCTCATCTCCCTCCAG-------------GCCCGGAGGGGCTGGAGAC Aff
 G  L  I  S  L  Q A  R  R  G  W  R
      720       730       740       750       760
-------+---------+---------+---------+---------+--
CCACGTGGAGAACGGCGGCGTCCTGGGCAGCCGCAAGGGCGTGAACCTGC Wt
  H  V  E  N  G  G  V  L  G  S  R  K  G  V  N  L 
CCACGTGGAGAACGGCGGCGTCCTGGGCAGCCGCAAGGGCGTGAACCTGC Aff
P  T  W  R  T  A  A  S  W  A  A  A  R  A X  .  . 
      770       780       790       800       810
-------+---------+---------+---------+---------+--
CCGGAACCCAGGTGGACCTGCCGGGGCTGTCCGAGCAGGATGCCCGGGAC Wt
P  G  T  Q  V  D  L  P  G  L  S  E  Q  D  A  R  D 
CCGGAACCCAGGTGGACCTGCCGGGGCTGTCCGAGCAGGATGCCCGGGAC Aff
 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 
      820       830       840       850       860
-------+---------+---------+---------+---------+--
CTGCGCTTCGGGGTGGAGCATGAGGTAGACATCGTGTTTGCCTCCTTTGT Wt
 L  R  F  G  V  E  H  E  V  D  I  V  F  A  S  F  V 
CTGCGCTTCGGGGTGGAGCATGAGGTAGACATCGTGTTTGCCTCCTTTGT Aff
  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .
      870       880       890       900
-------+---------+---------+---------+-----
GCGGAAAGCCAGTGACGTGGCTGCCATCCGGGAAGTTCTGGGG    Wt
  R  K  A  S  D  V  A  A  I  R  E  V  L  G 
GCGGAAAGCCAGTGACGTGGCTGCCATCCGGGAAGTTCTGGGG    Aff
.  .  .  .  .  .  .  .  .  .  .  .  .  .  . 
Figure 1 cDNA sequence and protein alignment of PKLR exons
5 and 6 for the domestic cat. Wild type (Wt) and affected (Aff)
exon 5 (underlined) and 6 cDNA sequence data are shown. Base
pair numbering is from the PKLR translation start. Protein translation
is shown below each cDNA sequence. Altered affected PKLR
protein is italicized in bold. A dot in the figure represents no
predicted protein translation product. Standard IUPAC nomenclature
is followed.








Figure 2 Partial genomic DNA intron 5 sequence of PKLR in the
domestic cat. Base pair positions are numbered from the exon 5
splice boundary. The correlated PK deficiency SNP is found at
position 304. Three non-affected cats (WTa, WTb, and BSH-British
shorthair) are shown as well as a carrier (Car) and affected (Aff). A
dot represents positions where the sequence data matched the
feline consensus (Con) sequence. Standard IUPAC nomenclature is
followed.
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and the cat homozygous for the putative causative
SNP for PKLR exon 5, intron 5 and exon 6 revealed
two SNPs in intron 5 at positions 304 and 320; a
G>A and C>T, respectively (Figure 2) (GenBank ac-
cession # JX951425). No other polymorphisms were
identified in this region or in the other genomic sequence
evaluated that included exons 2, 6 – 11, their intron-
exon boundaries and portions of the flanking intronic
regions. The c.693+304G>A mutation was concordant
with the cat PK deficiency phenotype, while the c.693
+320C>T mutation was homozygous in cats with no
clinical history of anemia and therefore presumed dis-
cordant. While typing submitted samples, LVS noted thatBritish Shorthairs contain a c.693+303C>T mutation on
the wild type allele that is discordant with the disease
phenotype.
Cat breed samples were submitted by owners to the
VGL and LVS for PK deficiency testing, which evaluated
the PKLR c.693+304G>A SNP. The cats submitted for
DNA testing represented a biased and unbiased sam-
pling for estimation of the SNP frequency (Table 1).
Biased samples included those specifically submitted for
PK deficiency testing (n = 3,084 - VGL, n = 1,506 - LVS)
and the unbiased samples were submitted for other cat-
specific DNA tests (n = 9,546 – VGL, n=43-LVS). Thirty-
seven breeds were submitted to the VGL and six to LVS,
representing 38 cat breeds from USA and UK popula-
tions. Cat samples submitted to the VGL were primarily
from United States sources but also included inter-
national submissions.
At least 10 unrelated individual cats were required to
represent a population in this study. The c.693+304G>A
PK deficiency-associated SNP is present at a frequency
of 6.31% for the entire sample set (Table 2). The
c.693+304G>A SNP was detected in 13 breeds, random
bred cats and unspecified cats and was absent in 25
breeds. The frequency of the c.693+304G>A increases to
9.35% when considering only these 15 groups that had
at least one presentation of the SNP. The frequency of
the c.693+304G>A SNP in unbiased samples from
breeds known to carry the SNP ranged from 0.078% in
the Exotic Shorthair to 12.97% in the Bengal (Table 3).
In submitted (biased) samples requesting PK deficiency
testing (Table 4), the SNP frequency ranged from 0.0%
in the Australian Mist cats to 41.4% in the Singapura
breed from the UK. United States PK deficiency test
requesting samples ranged from 11.75% in the Somali
to 23.0% in the Singapuras.
For 13 of 15 groups with the PK deficiency associated
SNP (Table 2) observed and expected genotypes based
on the SNP frequency in the populations did not deviate
significantly from expected Hardy -Weinberg ratios at
Table 2 Pyruvate kinase deficiency allele frequencies in cat breeds and populations
Breed Samples GG GA AA Freq. A Exp GG Exp GA Exp AA
Abyssinian* 1955 1476 465 14 0.126 1493 431 31
Abyssinian (UK) 36 28 8 0 0.11 29 7 0
American Bobtail 10 10 0
American SH 51 51 0
American Wirehair 11 11 0
Australian Mist (UK) 27 27 0
Balinese 39 39 0
Bengal* 1340 925 390 25 0.164 936 368 36
Bengal (UK) 1210 827 354 29 0.17 834 341 35
Birman 187 187 0
British SH 966 966 0
British SH (UK) 43 43 0
Burmese 118 118 0
Burmilla 38 38 0
Cornish Rex 46 46 0
Devon Rex 186 186 0
Domestic SH/LH 76 62 13 1 0.099 62 13 1
Egyptian Mau 36 27 9 0 0.1 28 8 1
Exotic LH 91 91 0
Exotic SH 645 644 1 0 0.0008 644 1 0
Himalayan 601 601 0
Korat 41 41 0
La Perm 56 40 16 0 0.14 41 14 1
Maine Coon 118 103 15 0 0.064 104 14 0
Munchkin 19 19 0
Norwegian Forest Cat 13 10 3 0 0.1 10 3 0
Ocicat 69 69 0
Oriental LH 48 48 0
Oriental SH 337 336 1 0 0.001 336 1 0
Persian 2226 2217 9 0 0.002 2217 9 0
Ragamuffin 20 20 0
Ragdoll 1063 1063 0
Russian Blue 14 14 0
Savannah Cat 11 10 1 0 0.05 10 1 0
Scottish Fold 68 68
Selkirk Rex 124 124
Siamese 457 457
Siberian Cat 377 360 16 1 0.024 359 18 0
Singapura 150 88 55 7 0.23 89 53 8
Singapura (UK) 168 60 77 31 0.414 58 81 29
Somali 633 527 104 2 0.0853 530 99 5
Somali (UK) 65 49 14 2 0.14 48 16 1
Sphynx 248 248
Turkish Angora 31 31
Unreported 111 98 13 0 0.059 99 12 0
Total 14179 12503 1564 112 0.063051 12447 1675 56
*=breeds significantly deviating for Hardy-Weinberg expected ratios.
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Table 3 Unbiased PK deficiency allele frequencies in 12 cat breeds based on samples submitted for other genetic
testing
Non - PK deficiency submitted samples (unbiased)
Breed # GG GA AA Freq. A Exp GG Exp GA Exp AA
Abyssinian 497 445 52 0 0.0523 447 49 1
Bengal 320 242 73 5 0.130 242 72 5
Domestic SH/LH 76 62 13 1 0.12 59 16 1
Egyptian Mau 36 27 9 0 0.13 27 8 1
Maine Coon 118 103 15 0 0.0636 103 14 0
Exotic SH 645 644 1 0 0.000775 644 1 0
Norwegian Forest Cat 13 10 3 0 0.12 10 3 0
Oriental SH 337 336 1 0 0.00148 336 1 0
Persian 2226 2217 9 0 0.002021 2217 9 0
Savannah 11 10 1 0 0.046 10 1 0
Siberian 377 360 16 1 0.0239 359 18 0
Somali 227 213 14 0 0.0308 213 14 0
unreported 111 98 13 0 0.0586 98 12 0
Total 4994 4767 220 7 0.0234 4763 229 3
Total (−Per, OSh, ExSh) 1786 1570 209 7 0.06234 1570 209 7
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were found for Bengals and Abyssinians at p = 0.05
and 0.001, respectively but only for the US populations.
Observed carriers were increased in the Bengals by 6.0%,
and homozygous affected individuals were decreased by
30.6%. In Abyssinians, carriers increased by 7.9% while
the observed homozygous affected cats decreased by
54.8%. When considering the biased versus unbiasedTable 4 Biased PK deficiency allele frequencies in six cat bree
Samples submitted for PK deficiency testing (biased)
Breed # GG GA AA
Abyssinian* 1458 1031 413 14
Abyssinian (UK) 36 28 8 0
Abyssinian Total 1494 1059 421 14
Aust Mist (UK) 27 27 0 0
Bengal* 1020 683 317 20
Bengal (UK) 1210 827 354 29
Bengal Total 2230 1510 671 39
La Perm 56 40 16 0
Singapura 150 88 55 7
Singapura (UK) 168 60 77 31
Singapura Total 318 148 132 38
Somali 400 308 90 2
Somali (UK) 65 49 14 2
Somali Total 465 357 104 4
Total US 3084 2150 891 43
Total UK 1506 991 453 62
Total 4590 3141 1344 105
*=breeds significantly deviating from Hardy-Weinberg expected ratios.Abyssinian and Bengal samples, the observed genotypes
for the unbiased sample sets had Hardy-Weinberg pre-
dicted genotype ratios. However, the biased sample set
significantly deviated at p = 0.001 for both data sets.
The Abyssinians had a 10.4% increase in carrier cats
and a 57.6% reduction in observed homozygous affected
cats while Bengal cats had a 35.5% reduction in observed
homozygous affected cats.ds based on samples submitted for PK testing
Freq. A Exp GG Exp GA Exp AA
0.1512 1051 374 33
0.11 29 7 0
0.1492 1080 381 33
0.0 27 0 0
0.1750 694 295 31
0.1702 833 342 35
0.1724 1527 637 66
0.1429 41 14 1
0.230 89 53 8
0.414 58 81 29
0.327 147 134 37
0.118 311 83 6
0.14 48 16 1
0.120 359 99 7
0.1584 2186 819 79
0.1916 968 446 65
0.1693 3113 1251 143
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Glycolysis is one of the principal pathways of energy
(ATP) generation in cells. In erythrocytes, glycolysis is
the only pathway for ATP synthesis since mature red
cells lack mitochondria. The most frequent glycolytic ab-
normality is PK deficiency. In humans, most mutations
are located in the coding sequences of PKLR, with mis-
sense, deletions, insertions, splice defects, premature
stop codons and promoter mutations, being common.
Humans, mice, dogs and cats have been documented to
have PK deficiency [22,23,25,27,29,32,41-43]. In cats, the
disease was first reported in Abyssinians and their long-
haired morph, the Somali, as well as in random bred cats
[31,32]. Subsequent to the reports in Abyssinians, bree-
ders and veterinarians have suggested that additional
breeds demonstrate the hallmarks of Abyssinian PK defi-
ciency by requesting the PK deficiency test from the ser-
vice laboratories.
In a 2005 detailed review, Zanella et al. [20] deter-
mined that 158 novel human PKLR mutations had been
identified. Subsequent population studies have increased
this total by over 44 novel mutations [18,44]. Mutations
are found in every exon, as well as several introns, all of
which result in human PK deficiency. The domestic cat
PKLR type-R CDS transcript has similar genetic se-
quence and structure to other mammalian species, with
~88% homology at both the DNA and protein sequence
level. Between species polymorphisms are distributed
across the transcript. This study demonstrated that cats
with PK deficiency produce transcripts with a 13 bp de-
letion at the 3' end of exon 5 of PKLR, however the
altered form was only confirmed in the R-type transcript
found in liver, bone marrow and blood. The deletion
results in the loss of 57% of the mature protein, likely
resulting in the disease phenotype. The only identified
and correlated genomic mutation is a guanine to adenine
transition in intron 5, 304 bp 3' of the exon 5 splice-
donor site and 53 bp upstream from the exon 6 splice-
acceptor site. The mechanism by which this mutation
results in the erroneous splicing of exons 5 and 6 has yet
to be determined. Several splice site variants have been
noted in human PK deficiency patients, and how these
affect splicing has not always been identified [45,46]. For
example, the effect of mutation IVS9 +43c on the mRNA
splicing cannot be directly demonstrated because the
aberrant mRNA transcript cannot be obtained. However,
the IVS9 +43c mutation is likely to be involved in PK
deficiency since the mutation is not found in normal
human populations, in silico splicing prediction suggests
introduction of a new acceptor splice site, and no other
sequence abnormalities were detected in the patient's
DNA [16]. Moreover, mutations in internal portions of
exons or introns, which result in aberrant splicing, have
been described in several disease-related genes [47,48].PK activity in the erythrocytes of carrier cats is esti-
mated as 50% the level of activity of the wild type [32]
yet the frequency in the random population may suggest
some selective advantage for cats with the mutation such
as blood -borne parasite infection resistance. Homozy-
gous cats that should have disease-associated presenta-
tions, such as splenomegaly, hemolytic anemia and
increased osmotic fragility of erythrocytes, are not being
actively reported by Bengal, Singapura and other breed
owners to the veterinary community possibly owing to
the fact that the disease can be episodic, mild and sub-
clinical [30]. In addition, the fact that expression of the
disease phenotype is variable both in the age of onset
and severity suggests that additional factors may be
required to induce disease, such as stress and activity
level [30]. Never the less, the lack of presentation of sick
cats is puzzling, prompting further investigation of the
c.693+304G>A PK deficiency-associated SNP.
PK deficiency was first documented in an Abyssinian
from the USA [32], and later in Abyssinian and Somali
cats in Germany and Australia [49,50]. A limited Australian
population study in Abyssinian and Somali cats (N = 60)
revealed a frequency of 0.13 and 0.29, respectively, of the
intronic SNP [34]. However, the authors noted that, al-
though multiple breeders were approached for inclusion,
participation may have been biased towards those with
known carrier cats. Additionally, related cats, including full
siblings, were used. Thus, the estimation of prevalence in
Australia may be significantly biased towards the affected
allele. Abyssinian and Bengal breeders have been actively
screening for the disease-associated SNP and represent
over 81% of samples submitted for PK deficiency testing.
The c.693+304G>A PK deficiency-associated SNP allele
frequency deviates from Hardy-Weinberg equilibrium
(p=0.05) (Table 2) only in these two breeds. The
Abyssinians, which have been tested for PK deficiency over
the longest interval, have a significant deficit from the pre-
dicted numbers of homozygous affected cats. The Bengals
also have a decrease in the observed numbers of homozy-
gous affected cats, although to a lesser extent. Increases in
the observed number of carriers in both breeds would sug-
gest that breeders are using genetic data to actively select
against matings that would produce affected offspring.
Moreover, lack of selection against the deleterious allele
in the remaining populations has allowed the c.693
+304G>A PK deficiency-associated SNP to persist and
results in higher percentages of affected cats in those
breeds.
In this study, the frequency of the c.693+304G>A PK
deficiency-associated SNP ranged from 3 – 15% in
Abyssinian and Somalis between the USA and UK. Al-
though Abyssinian and Somali breeders have known of the
health concern, no genetic test has been peer-reviewed
and published to ensure widespread detection of the
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the frequency of the c.693+304G>A PK deficiency-
associated SNP is ~13% in Bengals and Egyptian Maus,
two breeds that have used Abyssinians in their breed de-
velopment, and perhaps would have benefitted from better
knowledge of the potential of PK deficiency concerns. The
c.693+304G>A PKLR SNP is at a critically high level in the
Singapura with nearly 42% of UK tested cats having the
SNP. This sampling is likely biased as breeders with con-
cerns for the disease are submitting cat samples for testing.
However, the frequency in Bengals in the UK (16%) is
similar to the USA (18%) and nearly the same for unbiased
Bengal sampling in the USA (13%). The Singapura is also a
breed developed from Abyssinian stock [51]. Thus, the
introgression of the disease into so many distinct breeds is
not enigmatic. In Singapuras, the SNP frequency (32.7%)
is 2.6-fold greater than that of the remainder of the
affected breeds (12.47%). The Singapura is numerically
one of the smallest breeds and the high frequency likely
results from either a probable high frequency of the c.693
+304G>A PKLR SNP in the founder population or acci-
dental high inbreeding of affected cats during the breeds
inception in the 1970's. Lack of a diagnostic test in the
early stages of breed development and later, failure to dis-
close the genetic marker correlated with the disease un-
deniably contributed to the spread of the affected allele via
breed development programs.
The western breeds, Norwegian Forest cats, Siberians
and Maine Coons, are derived from regional feral popu-
lations in Scandinavia, Russia and the USA, respectively.
Considering the most probable explanation of identity
by decent, the presence of the c.693+304G>A PKLR
SNP in these three breeds presents an interesting conun-
drum regarding its origin. The SNP is present in random
bred cats (11% in 76 cats). It is possible that random
bred founder cats or local feral cats used in breed expan-
sion carried the allele. It is equally likely that a desirable
phenotype from an affected breed was introduced into
these populations and the affected allele was inadvert-
ently introduced as well.
The c.693+304G>A PKLR SNP allele frequency var-
ied across the populations evaluated. Samples repre-
senting 25 groups did not possess the SNP. Breeds
such as the Persians, Exotic and Oriental shorthairs
had frequencies less than 0.002, a 10-fold lower fre-
quency than found in the next lowest breed, the Siberian.
The nine carrier Persian samples were provided by
breeders from Japan (3), Chile (2), England (3) and the
Netherlands (1) and each set contained full siblings,
Netherlands excepted. Intentional or inadvertent incor-
rect breed designation by owners on submission forms
may account for the presence of c.693+304G>A PKLR
SNP in some breeds. Some breeders have acknowl-
edged providing incorrect breed identification whensubmitting samples for testing to circumvent commer-
cial laboratory rules limiting availability of tests that
have not been validated for a specific breed. Thus, the
breeds with extremely low frequencies may not actually
have affected alleles within their populations.
The entire PKLR type-R transcript has now been
sequenced. The lone transcript variant observed between
affected and wild-type alleles is a 13 bp deletion at the
3' end of exon 5. This mutation is correlated with an
intronic c.693+304G>A mutation. No other potentially
causative mutation was identified although two add-
itional intron 5 mutations are in close proximity to
the causative mutation. Of particular interest is the
British Shorthair c.693+303C>T mutation, located 1bp
from the correlated mutation (Figure 2), which is present
at a frequency of 27.9% but has no disease association.
Thus, both the nature and location of the c.693+304G>A
may be critical for disease presentation.
Conclusions
This study presents an extensive survey for the presence
and frequency of the c.693+304G>A PK deficiency-
associated SNP in 38 domestic cat breeds with 12 breeds
ranging from 2 - 16% for the SNP. Based upon allelic fre-
quency in random unbiased population sampling, PK test-
ing is recommended for several breeds including Bengals,
Egyptian Maus, La Perms, Maine Coon cats, Norwegian
Forest cats, Savannahs, Siberians, and Singapuras, in
addition to Abyssinians and Somalis. Breeds known to
have been derived from Abyssinian crosses such as the
Ocicat and novel breed development or out-crossing pro-
grams using Bengals or other affected breeds should test
as well. Future expanded testing will undeniably help
prevent breeding affected individuals and possibly allow
selective elimination of the c.693+304G>A PK deficiency-
associated SNP in domestic cat populations.
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